|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/56 | (2006.01) |
| A61L 9/04 | (2006.01) | ||
| A61K 31/045 | (2006.01) | ||
| A61K 31/573 | (2006.01) | ||
| A61K 47/14 | (2006.01) | ||
| A61P 17/06 | (2006.01) |
| (11) | Number of the document | 1885373 |
| (13) | Kind of document | T |
| (96) | European patent application number | 06750845.7 |
| Date of filing the European patent application | 2006-04-20 | |
| (97) | Date of publication of the European application | 2008-02-13 |
| (45) | Date of publication and mention of the grant of the patent | 2015-05-20 |
| (46) | Date of publication of the claims translation | 2015-11-25 |
| (86) | Number | PCT/US2006/014903 |
| Date | 2006-04-20 |
| (87) | Number | WO 2006/115987 |
| Date | 2006-11-02 |
| (30) | Number | Date | Country code |
| 674946 P | 2005-04-25 | US |
| (72) |
DOW, Gordon, J., US
STEWART, Daniel, M., US
|
| (73) |
Dow Pharmaceutical Sciences,
1330A Redwood Way, Petaluma, CA 94954-6542,
US
Dermalogix Partners, Inc., 672 US Route 1 PO Box 1510, Scarborough, ME 04070, US |
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Klobetazolio purškiamos kompozicijos panaudojimas psoriazės gydymui |
| USE OF A CLOBETASOL SPRAY FORMULATION TO TREAT PSORIASIS |
| Payment date | Validity (years) | Amount | |
| 2025-03-19 | 20 | 347.00 EUR |